Rosine G.
- Country
- France
- Department
- Service d’Oncologie Médicale Digestive et Gynécologique
Research Overview
- Evaluation of Pembrolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Neoadjuvant/Adjuvant Treatment of Gastric and Gastroesophageal Junction Adenocarcinoma
- A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab with or without Tiragolumab (Anti-Tigit Antibody) in Patients with Unresectable Esophageal Squamous Cell Carcinoma whose Cancers have not Progressed following Definitive Concurrent Chemoradiotherapy
- Phase 2/3 Randomized Study of BMS-986504 with Nab-Paclitaxel and Gemcitabine vs. Placebo in Metastatic Pancreatic Ductal Adenocarcinoma with Homozygous MTAP Deletion
Data & Insights
Has run more than one trial at 23 of 138 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in treating various forms of gastrointestinal cancers, with particular emphasis on colorectal cancer and gastric adenocarcinoma.
- Advanced Colorectal Cancer Management
- Gastrointestinal Stromal Tumors (GIST)
- Gastroesophageal Junction Adenocarcinoma
Expertise extends to treating both localized and metastatic disease states.
Precision Oncology
Focus on targeted therapeutic approaches for specific molecular subtypes including HER2-positive gastric cancers and KRAS G12C mutations in colorectal cancer.
- Molecular-Guided Therapy
- Biomarker-Driven Treatment
- Personalized Medicine Approaches
Specializes in matching specific genetic profiles with targeted treatments.
Immunotherapy Applications
Expertise in applying immunotherapy treatments across various gastrointestinal cancers, including microsatellite instability-high (MSI-H) tumors.
- Checkpoint Inhibitor Therapy
- Combination Immunotherapy
- Novel Immunotherapy Approaches
Focuses on innovative immunotherapy combinations and treatment strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.